{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:56:26Z","timestamp":1765230986063,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program of the National Institutes of Health National Cancer Institute"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.exphem.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T17:10:19Z","timestamp":1361293819000},"page":"518-529.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia"],"prefix":"10.1016","volume":"41","author":[{"given":"Sarah H.","family":"Beachy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Jo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariela Martinez","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Aplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2013.02.006_bib1","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1038\/sj.onc.1210760","article-title":"Hox genes in hematopoiesis and leukemogenesis","volume":"26","author":"Argiropoulos","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2013.02.006_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0168-9525(90)90253-3","article-title":"The structure of the homeodomain and its functional implications","volume":"6","author":"Gehring","year":"1990","journal-title":"Trends Genet"},{"key":"10.1016\/j.exphem.2013.02.006_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2401410","article-title":"Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells","volume":"13","author":"Kawagoe","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.02.006_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-1119(94)90380-8","article-title":"Identification of homeobox genes expressed in human haemopoietic progenitor cells","volume":"144","author":"Moretti","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.exphem.2013.02.006_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-472X(01)00757-3","article-title":"Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny","volume":"30","author":"Pineault","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2013.02.006_bib6","doi-asserted-by":"crossref","first-page":"12223","DOI":"10.1073\/pnas.91.25.12223","article-title":"Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells","volume":"91","author":"Sauvageau","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2013.02.006_bib7","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1182\/blood-2005-05-2003","article-title":"Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells","volume":"106","author":"Lawrence","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib8","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood.V89.6.1922","article-title":"Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis","volume":"89","author":"Lawrence","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib9","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1093\/emboj\/17.13.3714","article-title":"Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b","volume":"17","author":"Kroon","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2013.02.006_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ng0296-149","article-title":"Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias","volume":"12","author":"Nakamura","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2013.02.006_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng0296-159","article-title":"The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9","volume":"12","author":"Borrow","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2013.02.006_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.286.5439.531","article-title":"Molecular classification of cancer: class discovery and class prediction by gene expression monitoring","volume":"286","author":"Golub","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.exphem.2013.02.006_bib13","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1158\/0008-5472.CAN-08-2208","article-title":"Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects","volume":"68","author":"Harper","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2013.02.006_bib14","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1182\/blood-2011-07-328880","article-title":"NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights","volume":"118","author":"Gough","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.leu.2405074","article-title":"The role of CALM-AF10 gene fusion in acute leukemia","volume":"22","author":"Caudell","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.02.006_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2013.02.006_bib17","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2007-09-113597","article-title":"HOXA9 is required for survival in human MLL-rearranged acute leukemias","volume":"113","author":"Faber","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/sj.onc.1204174","article-title":"Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4:11) abnormality","volume":"20","author":"Rozovskaia","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2013.02.006_bib19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood-2002-09-2913","article-title":"CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage","volume":"102","author":"Asnafi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sj.leu.2403657","article-title":"A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias","volume":"19","author":"Speleman","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.02.006_bib21","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.4049\/jimmunol.0901121","article-title":"A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement","volume":"183","author":"Choi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2013.02.006_bib22","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1182\/blood.V118.21.2467.2467","article-title":"A NUP98-PHF23 transgenic mouse model develops AML and T-ALL","volume":"118","author":"Gough","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib23","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1128\/MCB.19.9.6355","article-title":"The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells","volume":"19","author":"Thorsteinsdottir","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2013.02.006_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood.V99.1.121","article-title":"Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion","volume":"99","author":"Thorsteinsdottir","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib25","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.V94.6.1855","article-title":"Promoter elements of vav drive transgene expression in\u00a0vivo throughout the hematopoietic compartment","volume":"94","author":"Ogilvy","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib26","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-06-3749","article-title":"Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice","volume":"67","author":"Caudell","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2013.02.006_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/blood.V100.1.246","article-title":"Bethesda proposals for classification of lymphoid neoplasms in mice","volume":"100","author":"Morse","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib28","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot5156","article-title":"The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in\u00a0vitro","author":"Holmes","year":"2009","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.exphem.2013.02.006_bib29","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1182\/blood-2002-08-2484","article-title":"Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1","volume":"101","author":"Pineault","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","article-title":"NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib31","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/MCB.20.9.3274-3285.2000","article-title":"Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression","volume":"20","author":"Calvo","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2013.02.006_bib32","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.onc.1203371","article-title":"HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis","volume":"19","author":"Schnabel","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2013.02.006_bib33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2013.02.006_bib34","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2008-04-154310","article-title":"Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization","volume":"113","author":"Popovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib35","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3324\/haematol.2010.023481","article-title":"Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia","volume":"95","author":"Schotte","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2013.02.006_bib36","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.leu.2404685","article-title":"Gene expression profiling of precursor T-cell lymphoblastic leukemia\/lymphoma identifies oncogenic pathways that are potential therapeutic targets","volume":"21","author":"Lin","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.02.006_bib37","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.exphem.2012.08.001","article-title":"Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes","volume":"40","author":"Novak","year":"2012","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2013.02.006_bib38","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1182\/blood-2008-02-138172","article-title":"NOTCH is a key regulator of human T-cell acute leukemia initiating cell activity","volume":"113","author":"Armstrong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib39","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1182\/blood-2006-01-039586","article-title":"Flt3 is dispensable to the Hoxa9\/Meis1 leukemogenic cooperation","volume":"109","author":"Morgado","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","article-title":"Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia","volume":"10","author":"Somervaille","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2013.02.006_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2011.06.020","article-title":"Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1\/AbdB-like HOX protein complex","volume":"20","author":"Heuser","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2013.02.006_bib42","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia","volume":"111","author":"Van Vlierberghe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","article-title":"HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (TALL)","volume":"106","author":"Soulier","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib44","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2002-10-3221","article-title":"Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation","volume":"102","author":"Ferrando","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.leu.2404410","article-title":"Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogenetique Hematologique","volume":"21","author":"Cauwelier","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2013.02.006_bib46","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2005-07-3013","article-title":"Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia\/lymphoma","volume":"107","author":"Lin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib47","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 mutations in mouse models of T-ALL","volume":"107","author":"O\u2019Neil","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.exphem.2013.02.006_bib49","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles","volume":"183","author":"Pear","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2013.02.006_bib50","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2003-07-2582","article-title":"Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia","volume":"103","author":"Kumar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2013.02.006_bib51","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature08036","article-title":"Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger","volume":"459","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2013.02.006_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.gene.2007.11.001","article-title":"Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-kappaB) and HOXA9","volume":"408","author":"Trivedi","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.exphem.2013.02.006_bib53","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.1158\/0008-5472.CAN-05-1691","article-title":"Continuous MLL-ENL expression is necessary to establish a \u201cHox Code\u201d and maintain immortalization of hematopoietic progenitor cells","volume":"65","author":"Horton","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2013.02.006_bib54","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1101\/gad.1602107","article-title":"Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential","volume":"21","author":"Wong","year":"2007","journal-title":"Genes Dev"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X13000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X13000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:30:22Z","timestamp":1759566622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X13000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0301472X13000544"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2013.02.006","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2013.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}